Dimerizatiori of Antimicrobial Peptides: A Promisi... - BV FAPESP
Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Dimerizatiori of Antimicrobial Peptides: A Promising Strategy to Enhance Antimicrobial Peptide Activity

Full text
Author(s):
Lorenzon, Esteban N. [1] ; Piccoli, Julia P. [2] ; Santos-Filho, Norival A. [3] ; Cilli, Eduardo M. [2]
Total Authors: 4
Affiliation:
[1] Univ Fed Jatai, Unidade Acad Especial Saude, Jatai, GO - Brazil
[2] UNESP Univ Estadual Paulista, Inst Quim, Araraquara, SP - Brazil
[3] UNESP Univ Estadual Paulista, Campus Expt Registro, Registro, SP - Brazil
Total Affiliations: 3
Document type: Review article
Source: PROTEIN AND PEPTIDE LETTERS; v. 26, n. 2, p. 98-107, 2019.
Web of Science Citations: 1
Abstract

Antimicrobial resistance is a global health problem with strong social and economic impacts. The development of new antimicrobial agents is considered an urgent challenge. In this regard, Antimicrobial Peptides (AMPs) appear to he novel candidates to overcome this problem. The mechanism of action of AMPs involves intracellular targets and membrane disruption. Although the exact mechanism of action of AMPs remains controversial, most AMPs act through membrane disruption of the target cell. Several strategies have been used to improve AMP activity-, such as peptide dimerization. In this review, we focus on AMP dimerization, showing many examples of dimerized peptides and their effects on biological activity. Although more studies are necessary to elucidate the relationship between peptide properties and the dimerization effect on antimicrobial activity, dimerization constitutes a promising strategy to improve the effectiveness of AMPs. (AU)

FAPESP's process: 12/15346-7 - Antimicrobial peptides: dimerization effects and encapsulation in NRLb biomembrane
Grantee:Eduardo Maffud Cilli
Support Opportunities: Regular Research Grants
FAPESP's process: 13/07600-3 - CIBFar - Center for Innovation in Biodiversity and Drug Discovery
Grantee:Glaucius Oliva
Support Opportunities: Research Grants - Research, Innovation and Dissemination Centers - RIDC